LINC01116 and prostate adenocarcinoma: Yu et al. (2021) suggested that LINC01116 was an oncogene that accelerates the development of prostate adenocarcinoma (PRAD) cells. Fang et al. (2018) reported that the proliferation and migration of EOC cells was increased with the overexpression of LINC01116. Knockdown of LINC01116 could function as an essential suppressor to block the viability and cloning ability of BC cells (Hu et al., 2018).